Skip to main content
Top
Published in: NeuroMolecular Medicine 2/2008

01-06-2008 | Original Paper

Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis

Authors: Mary E. McCrate, Brian K. Kaspar

Published in: NeuroMolecular Medicine | Issue 2/2008

Login to get access

Abstract

Physical exercise exerts a wide range of benefits on an organism’s overall health and well-being. Exercise contributes positively toward an individual’s healthy weight, muscle strength, immune system, and cardiovascular health. Indeed, exercise has been demonstrated to reduce life-threatening conditions such as high blood pressure, heart disease, obesity, and diabetes. Of particular interest to this review, exercise has also been shown to be neuroprotective in both the central and peripheral nervous systems. Naturally, such findings apply broadly to the study of neurodegenerative disease with numerous reports demonstrating that exercise has beneficial effects on disease progression. One of the most devastating neurodegenerative diseases is amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease in the United States, or motor neuron disease in the United Kingdom, resulting from the progressive loss of brain and spinal cord motor neurons. Several human studies show that moderate exercise regimens improve ALS patients’ scoring on functionality tests and ameliorate disease symptoms. Other promising recent works using transgenic mouse models of familial ALS have shown markedly slowed disease progression, improved function, and extension of survival in moderately exercised animals. Possible explanations for these findings include the exercise-induced changes in motor neuron morphology, muscle-nerve interaction, glial activation, and altering levels of gene expression of anti-apoptotic proteins and neurotrophic factors in the active tissue. Here we review the current literature on exercise and motor neuron disease, focusing on rodent and human studies to define the proper type, intensity, and duration of exercise necessary to enhance neuron survival as well discuss current mechanistic studies to further define the exercise-mediated pathways of neuroprotection.
Literature
go back to reference Abbott, N. J., Ronnback, L., & Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience, 7, 41–53.PubMedCrossRef Abbott, N. J., Ronnback, L., & Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience, 7, 41–53.PubMedCrossRef
go back to reference Agre, J. C., Rodriquez, A. A., & Franke, T. M. (1997). Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Archive of Physics Medical Rehabilitation, 78, 681–686.CrossRef Agre, J. C., Rodriquez, A. A., & Franke, T. M. (1997). Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Archive of Physics Medical Rehabilitation, 78, 681–686.CrossRef
go back to reference ALS CNS Treatment Group. (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology, 46, 1244–1249. ALS CNS Treatment Group. (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology, 46, 1244–1249.
go back to reference Armon, C. (2007). Sports and trauma in amyotrophic lateral sclerosis revisited. Journal of the Neurological Sciences, 262, 45–53.PubMedCrossRef Armon, C. (2007). Sports and trauma in amyotrophic lateral sclerosis revisited. Journal of the Neurological Sciences, 262, 45–53.PubMedCrossRef
go back to reference Azzouz, M., Ralph, G. S., Storkebaum, E., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429, 413–417.PubMedCrossRef Azzouz, M., Ralph, G. S., Storkebaum, E., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429, 413–417.PubMedCrossRef
go back to reference BDNF Study Group (1999). A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology, 52, 1427–1433. BDNF Study Group (1999). A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology, 52, 1427–1433.
go back to reference Bello-Haas, V. D., Florence, J. M., Kloos, A. D., et al. (2007). A randomized controlled trial of resistance exercise in individuals with ALS. Neurology, 68, 2003–2007.PubMedCrossRef Bello-Haas, V. D., Florence, J. M., Kloos, A. D., et al. (2007). A randomized controlled trial of resistance exercise in individuals with ALS. Neurology, 68, 2003–2007.PubMedCrossRef
go back to reference Boillee, S., Vande Velde, C., & Cleveland, D. W. (2006a). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39–59.PubMedCrossRef Boillee, S., Vande Velde, C., & Cleveland, D. W. (2006a). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39–59.PubMedCrossRef
go back to reference Boillee, S., Yamanaka, K., Lobsiger, C. S., et al. (2006b). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389–1392.PubMedCrossRef Boillee, S., Yamanaka, K., Lobsiger, C. S., et al. (2006b). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389–1392.PubMedCrossRef
go back to reference Bruijn, L. I., Becher, M. W., Lee, M. K., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–338.PubMedCrossRef Bruijn, L. I., Becher, M. W., Lee, M. K., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–338.PubMedCrossRef
go back to reference Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723–749.PubMedCrossRef Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723–749.PubMedCrossRef
go back to reference Carro, E., Nunez, A., Busiguina, S., & Torres-Aleman, I. (2000). Circulating insulin-like growth factor I mediates effects of exercise on the brain. Journal of Neurosciences, 20, 2926–2933. Carro, E., Nunez, A., Busiguina, S., & Torres-Aleman, I. (2000). Circulating insulin-like growth factor I mediates effects of exercise on the brain. Journal of Neurosciences, 20, 2926–2933.
go back to reference Carro, E., Trejo, J. L., Busiguina, S., & Torres-Aleman, I. (2001). Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. Journal of Neurosciences, 21, 5678–5684. Carro, E., Trejo, J. L., Busiguina, S., & Torres-Aleman, I. (2001). Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. Journal of Neurosciences, 21, 5678–5684.
go back to reference Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002). Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nature Medicine, 8, 1390–1397.PubMedCrossRef Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002). Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nature Medicine, 8, 1390–1397.PubMedCrossRef
go back to reference Carro, E., Trejo, J. L., Nunez, A., & Torres-Aleman, I. (2003). Brain repair and neuroprotection by serum insulin-like growth factor I. Molecular Neurobiology, 27, 153–162.PubMedCrossRef Carro, E., Trejo, J. L., Nunez, A., & Torres-Aleman, I. (2003). Brain repair and neuroprotection by serum insulin-like growth factor I. Molecular Neurobiology, 27, 153–162.PubMedCrossRef
go back to reference Chan, K. M., Amirjani, N., Sumrain, M., Clarke, A., & Strohschein, F. J. (2003). Randomized controlled trial of strength training in post-polio patients. Muscle Nerve, 27, 332–338.PubMedCrossRef Chan, K. M., Amirjani, N., Sumrain, M., Clarke, A., & Strohschein, F. J. (2003). Randomized controlled trial of strength training in post-polio patients. Muscle Nerve, 27, 332–338.PubMedCrossRef
go back to reference Chio, A., Benzi, G., Dossena, M., Mutani, R., & Mora, G. (2005). Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 128, 472–476.PubMedCrossRef Chio, A., Benzi, G., Dossena, M., Mutani, R., & Mora, G. (2005). Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 128, 472–476.PubMedCrossRef
go back to reference Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2, 806–819.PubMedCrossRef Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2, 806–819.PubMedCrossRef
go back to reference Cotman, C. W., & Berchtold, N. C. (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neuroscience, 25, 295–301.CrossRef Cotman, C. W., & Berchtold, N. C. (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neuroscience, 25, 295–301.CrossRef
go back to reference Cudkowicz, M. E., McKenna-Yasek, D., Sapp, P. E., et al. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Annual of Neurology, 41, 210–221.CrossRef Cudkowicz, M. E., McKenna-Yasek, D., Sapp, P. E., et al. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Annual of Neurology, 41, 210–221.CrossRef
go back to reference Ding, Y. H., Luan, X. D., Li, J., et al. (2004). Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Current Neurovascular Research, 1, 411–420.PubMedCrossRef Ding, Y. H., Luan, X. D., Li, J., et al. (2004). Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Current Neurovascular Research, 1, 411–420.PubMedCrossRef
go back to reference Dobrowolny, G., Giacinti, C., Pelosi, L., et al. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. The Journal of Cell Biology, 168, 193–199.PubMedCrossRef Dobrowolny, G., Giacinti, C., Pelosi, L., et al. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. The Journal of Cell Biology, 168, 193–199.PubMedCrossRef
go back to reference Drory, V. E., Goltsman, E., Reznik, J. G., Mosek, A., & Korczyn, A. D. (2001). The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191, 133–137.PubMedCrossRef Drory, V. E., Goltsman, E., Reznik, J. G., Mosek, A., & Korczyn, A. D. (2001). The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191, 133–137.PubMedCrossRef
go back to reference Dupuis, L., Oudart, H., Rene, F., Gonzalez de Aguilar, J. L., & Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101, 11159–11164.PubMedCrossRef Dupuis, L., Oudart, H., Rene, F., Gonzalez de Aguilar, J. L., & Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101, 11159–11164.PubMedCrossRef
go back to reference Durham, H. D., Roy, J., Dong, L., & Figlewicz, D. A. (1997). Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. Journal of Neuropathology and Experimental Neurology, 56, 523–530.PubMedCrossRef Durham, H. D., Roy, J., Dong, L., & Figlewicz, D. A. (1997). Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. Journal of Neuropathology and Experimental Neurology, 56, 523–530.PubMedCrossRef
go back to reference Eisen, A., Schulzer, M., MacNeil, M., Pant, B., & Mak, E. (1993). Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve, 16, 27–32.PubMedCrossRef Eisen, A., Schulzer, M., MacNeil, M., Pant, B., & Mak, E. (1993). Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve, 16, 27–32.PubMedCrossRef
go back to reference Engesser-Cesar, C., Anderson, A. J., Basso, D. M., Edgerton, V. R., & Cotman, C. W. (2005). Voluntary wheel running improves recovery from a moderate spinal cord injury. Journal of Neurotrauma, 22, 157–171.PubMedCrossRef Engesser-Cesar, C., Anderson, A. J., Basso, D. M., Edgerton, V. R., & Cotman, C. W. (2005). Voluntary wheel running improves recovery from a moderate spinal cord injury. Journal of Neurotrauma, 22, 157–171.PubMedCrossRef
go back to reference Engesser-Cesar, C., Ichiyama, R. M., Nefas, A. L., et al. (2007). Wheel running following spinal cord injury improves locomotor recovery and stimulates serotonergic fiber growth. European Journal of Neuroscience, 25, 1931–1939.PubMedCrossRef Engesser-Cesar, C., Ichiyama, R. M., Nefas, A. L., et al. (2007). Wheel running following spinal cord injury improves locomotor recovery and stimulates serotonergic fiber growth. European Journal of Neuroscience, 25, 1931–1939.PubMedCrossRef
go back to reference Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007). Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Research, 1157, 126–137.PubMedCrossRef Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007). Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Research, 1157, 126–137.PubMedCrossRef
go back to reference Gardiner, P., Dai, Y., & Heckman, C. J. (2006). Effects of exercise training on alpha-motoneurons. Journal of Applied Physiology, 101, 1228–1236.PubMedCrossRef Gardiner, P., Dai, Y., & Heckman, C. J. (2006). Effects of exercise training on alpha-motoneurons. Journal of Applied Physiology, 101, 1228–1236.PubMedCrossRef
go back to reference Grondard, C., Biondi, O., Armand, A. S., et al. (2005). Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. Journal of Neuroscience, 25, 7615–7622.PubMedCrossRef Grondard, C., Biondi, O., Armand, A. S., et al. (2005). Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. Journal of Neuroscience, 25, 7615–7622.PubMedCrossRef
go back to reference Gruzman, A., Wood, W. L., Alpert, E., et al. (2007). Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 104, 12524–12529.PubMedCrossRef Gruzman, A., Wood, W. L., Alpert, E., et al. (2007). Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 104, 12524–12529.PubMedCrossRef
go back to reference Gubbay, S. S., Kahana, E., Zilber, N., Cooper, G., Pintov, S., & Leibowitz, Y. (1985). Amyotrophic lateral sclerosis. A study of its presentation and prognosis. Journal of Neurology, 232, 295–300.PubMedCrossRef Gubbay, S. S., Kahana, E., Zilber, N., Cooper, G., Pintov, S., & Leibowitz, Y. (1985). Amyotrophic lateral sclerosis. A study of its presentation and prognosis. Journal of Neurology, 232, 295–300.PubMedCrossRef
go back to reference Gurney, M. E., Pu, H., Chiu, A. Y., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772–1775.PubMedCrossRef Gurney, M. E., Pu, H., Chiu, A. Y., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772–1775.PubMedCrossRef
go back to reference Hamadeh, M. J., Rodriguez, M. C., Kaczor, J. J., & Tarnopolsky, M. A. (2005). Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve, 31, 214–220.PubMedCrossRef Hamadeh, M. J., Rodriguez, M. C., Kaczor, J. J., & Tarnopolsky, M. A. (2005). Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve, 31, 214–220.PubMedCrossRef
go back to reference Horton, W. A., Eldridge, R., & Brody, J. A. (1976). Familial motor neuron disease. Evidence for at least three different types. Neurology, 26, 460–465.PubMed Horton, W. A., Eldridge, R., & Brody, J. A. (1976). Familial motor neuron disease. Evidence for at least three different types. Neurology, 26, 460–465.PubMed
go back to reference Hutchinson, K. J., Gomez-Pinilla, F., Crowe, M. J., Ying, Z., & Basso, D. M. (2004). Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain, 127, 1403–1414.PubMedCrossRef Hutchinson, K. J., Gomez-Pinilla, F., Crowe, M. J., Ying, Z., & Basso, D. M. (2004). Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain, 127, 1403–1414.PubMedCrossRef
go back to reference Ischiropoulos, H., Zhu, L., Chen, J., et al. (1992). Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Archives of Biochemistry and Biophysics, 298, 431–437.PubMedCrossRef Ischiropoulos, H., Zhu, L., Chen, J., et al. (1992). Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Archives of Biochemistry and Biophysics, 298, 431–437.PubMedCrossRef
go back to reference Jablecki, C. K., Berry, C., & Leach, J. (1989). Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve, 12, 833–841.PubMedCrossRef Jablecki, C. K., Berry, C., & Leach, J. (1989). Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve, 12, 833–841.PubMedCrossRef
go back to reference Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1987). Fast axonal transport of acetylcholinesterase in rat sciatic motoneurons is enhanced following prolonged daily running, but not following swimming. Neuroscience Letters, 78, 156–160.PubMedCrossRef Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1987). Fast axonal transport of acetylcholinesterase in rat sciatic motoneurons is enhanced following prolonged daily running, but not following swimming. Neuroscience Letters, 78, 156–160.PubMedCrossRef
go back to reference Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1988). Fast axonal transport of labeled proteins in motoneurons of exercise-trained rats. American Journal of Physiology, 255, C731–736.PubMed Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1988). Fast axonal transport of labeled proteins in motoneurons of exercise-trained rats. American Journal of Physiology, 255, C731–736.PubMed
go back to reference Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., et al. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7, 1162–1167.PubMedCrossRef Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., et al. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7, 1162–1167.PubMedCrossRef
go back to reference Julien, J. P. (2007). ALS: astrocytes move in as deadly neighbors. Nature of Neuroscience, 10, 535–537.CrossRef Julien, J. P. (2007). ALS: astrocytes move in as deadly neighbors. Nature of Neuroscience, 10, 535–537.CrossRef
go back to reference Kaspar, B. K., Frost, L. M., Christian, L., Umapathi, P., & Gage, F. H. (2005). Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology, 57, 649–655.PubMedCrossRef Kaspar, B. K., Frost, L. M., Christian, L., Umapathi, P., & Gage, F. H. (2005). Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology, 57, 649–655.PubMedCrossRef
go back to reference Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301, 839–842.PubMedCrossRef Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301, 839–842.PubMedCrossRef
go back to reference Kim, S. U., & de Vellis, J. (2005). Microglia in health and disease. Journal of Neuroscience Research, 81, 302–313.PubMedCrossRef Kim, S. U., & de Vellis, J. (2005). Microglia in health and disease. Journal of Neuroscience Research, 81, 302–313.PubMedCrossRef
go back to reference Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2003). Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Annals of Neurology, 53, 804–807.PubMedCrossRef Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2003). Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Annals of Neurology, 53, 804–807.PubMedCrossRef
go back to reference Kleim, J. A., Cooper, N. R., & VandenBerg, P. M. (2002). Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Research, 934, 1–6.PubMedCrossRef Kleim, J. A., Cooper, N. R., & VandenBerg, P. M. (2002). Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Research, 934, 1–6.PubMedCrossRef
go back to reference Kleim, J. A., Jones, T. A., & Schallert, T. (2003). Motor enrichment and the induction of plasticity before or after brain injury. Neurochemical Research, 28, 1757–1769.PubMedCrossRef Kleim, J. A., Jones, T. A., & Schallert, T. (2003). Motor enrichment and the induction of plasticity before or after brain injury. Neurochemical Research, 28, 1757–1769.PubMedCrossRef
go back to reference Kurtzke, J. F. (1991). Risk factors in amyotrophic lateral sclerosis. Advanced Neurology, 56, 245–270. Kurtzke, J. F. (1991). Risk factors in amyotrophic lateral sclerosis. Advanced Neurology, 56, 245–270.
go back to reference Lambrechts, D., & Carmeliet, P. (2006). VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta, 1762, 1109–1121.PubMed Lambrechts, D., & Carmeliet, P. (2006). VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta, 1762, 1109–1121.PubMed
go back to reference Lepore, A. C., Haenggeli, C., Gasmi, M., et al. (2007). Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1(G93A) model of ALS. Brain Research [epub]. Lepore, A. C., Haenggeli, C., Gasmi, M., et al. (2007). Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1(G93A) model of ALS. Brain Research [epub].
go back to reference Li, J., Ding, Y. H., Rafols, J. A., Lai, Q., McAllister, J. P., 2nd, & Ding, Y. (2005). Increased astrocyte proliferation in rats after running exercise. Neuroscience Letters, 386, 160–164.PubMedCrossRef Li, J., Ding, Y. H., Rafols, J. A., Lai, Q., McAllister, J. P., 2nd, & Ding, Y. (2005). Increased astrocyte proliferation in rats after running exercise. Neuroscience Letters, 386, 160–164.PubMedCrossRef
go back to reference Liebetanz, D., Hagemann, K., von Lewinski, F., Kahler, E., & Paulus, W. (2004). Extensive exercise is not harmful in amyotrophic lateral sclerosis. European Journal of Neuroscience, 20, 3115–3120.PubMedCrossRef Liebetanz, D., Hagemann, K., von Lewinski, F., Kahler, E., & Paulus, W. (2004). Extensive exercise is not harmful in amyotrophic lateral sclerosis. European Journal of Neuroscience, 20, 3115–3120.PubMedCrossRef
go back to reference Longstreth, W. T., McGuire, V., Koepsell, T. D., Wang, Y., & van Belle, G. (1998). Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Archives of Neurology, 55, 201–206.PubMedCrossRef Longstreth, W. T., McGuire, V., Koepsell, T. D., Wang, Y., & van Belle, G. (1998). Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Archives of Neurology, 55, 201–206.PubMedCrossRef
go back to reference Mahoney, D. J., Rodriguez, C., Devries, M., Yasuda, N., & Tarnopolsky, M. A. (2004). Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve, 29, 656–662.PubMedCrossRef Mahoney, D. J., Rodriguez, C., Devries, M., Yasuda, N., & Tarnopolsky, M. A. (2004). Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve, 29, 656–662.PubMedCrossRef
go back to reference Mattiazzi, M., D’Aurelio, M., Gajewski, C. D., et al. (2002). Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. Journal of Biological Chemistry, 277, 29626–29633.PubMedCrossRef Mattiazzi, M., D’Aurelio, M., Gajewski, C. D., et al. (2002). Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. Journal of Biological Chemistry, 277, 29626–29633.PubMedCrossRef
go back to reference Mattson, M. P., Cutler, R. G., & Camandola, S. (2007). Energy intake and amyotrophic lateral sclerosis. NeuroMolecular Medicine, 9, 17–20.PubMedCrossRef Mattson, M. P., Cutler, R. G., & Camandola, S. (2007). Energy intake and amyotrophic lateral sclerosis. NeuroMolecular Medicine, 9, 17–20.PubMedCrossRef
go back to reference Miller, R. G., Petajan, J. H., Bryan, W. W., et al. (1996). A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Annals of Neurology, 39, 256–260.PubMedCrossRef Miller, R. G., Petajan, J. H., Bryan, W. W., et al. (1996). A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Annals of Neurology, 39, 256–260.PubMedCrossRef
go back to reference Mitchell, J., Wokke, J., & Borasio, G. (2007). Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews, CD002064. Mitchell, J., Wokke, J., & Borasio, G. (2007). Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews, CD002064.
go back to reference Mulder, D. W., Kurland, L. T., Offord, K. P., & Beard, C. M. (1986). Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology, 36, 511–517.PubMed Mulder, D. W., Kurland, L. T., Offord, K. P., & Beard, C. M. (1986). Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology, 36, 511–517.PubMed
go back to reference Munsat, T. L., Andres, P. L., Finison, L., Conlon, T., & Thibodeau, L. (1988). The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology, 38, 409–413.PubMed Munsat, T. L., Andres, P. L., Finison, L., Conlon, T., & Thibodeau, L. (1988). The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology, 38, 409–413.PubMed
go back to reference Nagano, I., Ilieva, H., Shiote, M., et al. (2005). Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. Journal of the Neurological Sciences, 235, 61–68.PubMedCrossRef Nagano, I., Ilieva, H., Shiote, M., et al. (2005). Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. Journal of the Neurological Sciences, 235, 61–68.PubMedCrossRef
go back to reference Narai, H., Nagano, I., Ilieva, H., et al. (2005). Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. Journal of Neuroscience Research, 82, 452–457.PubMedCrossRef Narai, H., Nagano, I., Ilieva, H., et al. (2005). Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. Journal of Neuroscience Research, 82, 452–457.PubMedCrossRef
go back to reference Nathanson, N., & Martin, J. R. (1979). The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. American Journal of Epidemiology, 110, 672–692.PubMed Nathanson, N., & Martin, J. R. (1979). The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. American Journal of Epidemiology, 110, 672–692.PubMed
go back to reference Pinto, A. C., Alves, M., Nogueira, A., et al. (1999). Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J. Neurological Sciences, 169, 69–75.CrossRef Pinto, A. C., Alves, M., Nogueira, A., et al. (1999). Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J. Neurological Sciences, 169, 69–75.CrossRef
go back to reference Qureshi, M. M., Hayden, D., Urbinelli, L., et al. (2006). Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis, 7, 173–182.PubMedCrossRef Qureshi, M. M., Hayden, D., Urbinelli, L., et al. (2006). Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis, 7, 173–182.PubMedCrossRef
go back to reference Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 92, 689–693.PubMedCrossRef Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 92, 689–693.PubMedCrossRef
go back to reference Rosen, D. R., Siddique, T., Patterson, D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62.PubMedCrossRef Rosen, D. R., Siddique, T., Patterson, D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62.PubMedCrossRef
go back to reference Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002). Premorbid weight, body mass, and varsity athletics in ALS. Neurology, 59, 773–775.PubMed Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002). Premorbid weight, body mass, and varsity athletics in ALS. Neurology, 59, 773–775.PubMed
go back to reference Storkebaum, E., Lambrechts, D., Dewerchin, M., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature of Neuroscience, 8, 85–92.CrossRef Storkebaum, E., Lambrechts, D., Dewerchin, M., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature of Neuroscience, 8, 85–92.CrossRef
go back to reference Strickland, D., Smith, S. A., Dolliff, G., Goldman, L., & Roelofs, R. I. (1996). Physical activity, trauma, and ALS: a case-control study. Acta Neurologica Scandinavica, 94, 45–50.PubMedCrossRef Strickland, D., Smith, S. A., Dolliff, G., Goldman, L., & Roelofs, R. I. (1996). Physical activity, trauma, and ALS: a case-control study. Acta Neurologica Scandinavica, 94, 45–50.PubMedCrossRef
go back to reference Swain, R. A., Harris, A. B., Wiener, E. C., et al. (2003). Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience, 117, 1037–1046.PubMedCrossRef Swain, R. A., Harris, A. B., Wiener, E. C., et al. (2003). Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience, 117, 1037–1046.PubMedCrossRef
go back to reference Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature of Neuroscience, 9, 108–118.CrossRef Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature of Neuroscience, 9, 108–118.CrossRef
go back to reference van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000). Delaying the onset of Huntington’s in mice. Nature, 404, 721–722.PubMedCrossRef van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000). Delaying the onset of Huntington’s in mice. Nature, 404, 721–722.PubMedCrossRef
go back to reference Veldink, J. H., Bar, P. R., Joosten, E. A., Otten, M., Wokke, J. H., & van den Berg, L. H. (2003). Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscular Disorders, 13, 737–743.PubMedCrossRef Veldink, J. H., Bar, P. R., Joosten, E. A., Otten, M., Wokke, J. H., & van den Berg, L. H. (2003). Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscular Disorders, 13, 737–743.PubMedCrossRef
go back to reference Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Titulaer, M. J., Wokke, J. H., & van den Berg, L. H. (2005). Physical activity and the association with sporadic ALS. Neurology, 64, 241–245.PubMed Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Titulaer, M. J., Wokke, J. H., & van den Berg, L. H. (2005). Physical activity and the association with sporadic ALS. Neurology, 64, 241–245.PubMed
go back to reference Wiedau-Pazos, M., Goto, J. J., Rabizadeh, S., et al. (1996). Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science, 271, 515–518.PubMedCrossRef Wiedau-Pazos, M., Goto, J. J., Rabizadeh, S., et al. (1996). Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science, 271, 515–518.PubMedCrossRef
go back to reference Wood, J. D., Beaujeux, T. P., & Shaw, P. J. (2003). Protein aggregation in motor neurone disorders. Neuropathology and Applied Neurobiology, 29, 529–545.PubMedCrossRef Wood, J. D., Beaujeux, T. P., & Shaw, P. J. (2003). Protein aggregation in motor neurone disorders. Neuropathology and Applied Neurobiology, 29, 529–545.PubMedCrossRef
go back to reference Wu, D., Yu, W., Kishikawa, H., et al. (2007). Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Annals of Neurology, 62, 609–617.PubMedCrossRef Wu, D., Yu, W., Kishikawa, H., et al. (2007). Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Annals of Neurology, 62, 609–617.PubMedCrossRef
go back to reference Yamanaka, K., Chun, S. J., Boillee, S., et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11, 1–3.CrossRef Yamanaka, K., Chun, S. J., Boillee, S., et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11, 1–3.CrossRef
Metadata
Title
Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis
Authors
Mary E. McCrate
Brian K. Kaspar
Publication date
01-06-2008
Publisher
Humana Press Inc
Published in
NeuroMolecular Medicine / Issue 2/2008
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-008-8030-5

Other articles of this Issue 2/2008

NeuroMolecular Medicine 2/2008 Go to the issue